[go: up one dir, main page]

RU2018140900A3 - - Google Patents

Download PDF

Info

Publication number
RU2018140900A3
RU2018140900A3 RU2018140900A RU2018140900A RU2018140900A3 RU 2018140900 A3 RU2018140900 A3 RU 2018140900A3 RU 2018140900 A RU2018140900 A RU 2018140900A RU 2018140900 A RU2018140900 A RU 2018140900A RU 2018140900 A3 RU2018140900 A3 RU 2018140900A3
Authority
RU
Russia
Application number
RU2018140900A
Other versions
RU2018140900A (ru
RU2768283C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58668875&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2018140900(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2018140900A publication Critical patent/RU2018140900A/ru
Publication of RU2018140900A3 publication Critical patent/RU2018140900A3/ru
Application granted granted Critical
Publication of RU2768283C2 publication Critical patent/RU2768283C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
RU2018140900A 2016-04-28 2017-04-28 Семаглутид при сердечно-сосудистых состояниях RU2768283C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP16167458 2016-04-28
EP16167458.5 2016-04-28
EP16188262 2016-09-12
EP16188262.6 2016-09-12
PCT/EP2017/060160 WO2017186896A1 (en) 2016-04-28 2017-04-28 Semaglutide in cardiovascular conditions

Publications (3)

Publication Number Publication Date
RU2018140900A RU2018140900A (ru) 2020-05-28
RU2018140900A3 true RU2018140900A3 (ru) 2020-09-28
RU2768283C2 RU2768283C2 (ru) 2022-03-23

Family

ID=58668875

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018140900A RU2768283C2 (ru) 2016-04-28 2017-04-28 Семаглутид при сердечно-сосудистых состояниях

Country Status (24)

Country Link
US (3) US20190134162A1 (ru)
EP (1) EP3448416B1 (ru)
JP (1) JP7221694B2 (ru)
KR (3) KR102778218B1 (ru)
CN (1) CN109069589B (ru)
AU (2) AU2017256774B2 (ru)
BR (1) BR112018072020A2 (ru)
CA (1) CA3022535A1 (ru)
CL (1) CL2018003045A1 (ru)
DK (1) DK3448416T3 (ru)
ES (1) ES2928007T3 (ru)
HR (1) HRP20221150T1 (ru)
HU (1) HUE060040T2 (ru)
IL (1) IL262390B1 (ru)
MA (1) MA44762A (ru)
MX (1) MX2018012700A (ru)
MY (1) MY202967A (ru)
PH (1) PH12018502274B1 (ru)
PL (1) PL3448416T3 (ru)
RS (1) RS63630B1 (ru)
RU (1) RU2768283C2 (ru)
SI (1) SI3448416T1 (ru)
WO (1) WO2017186896A1 (ru)
ZA (2) ZA202507394B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2928007T3 (es) 2016-04-28 2022-11-14 Novo Nordisk As Semaglutida en afecciones cardiovasculares
MA46990B1 (fr) 2017-08-24 2024-03-29 Novo Nordisk As Compositions glp-1 et ses utilisations
PE20211492A1 (es) * 2018-10-26 2021-08-11 Novo Nordisk As Composiciones estables de semaglutida y usos de las mismas
CN113194929B (zh) * 2018-12-21 2022-12-09 诺和诺德股份有限公司 Glp-1肽的喷雾干燥工艺
TW202535454A (zh) * 2020-02-18 2025-09-16 丹麥商諾佛 儂迪克股份有限公司 醫藥配方
CN114699510B (zh) * 2021-12-29 2024-07-16 浙江湃肽生物有限公司 一种司美格鲁肽微针阵列及其制备方法
CN119317635A (zh) * 2022-06-08 2025-01-14 载度思生命科学有限公司 用于2型糖尿病和体重管理的可重复使用的多剂量可变剂量的单一笔式注射器
CN117462654A (zh) * 2023-09-28 2024-01-30 武汉大学人民医院(湖北省人民医院) 司美格鲁肽在制备预防或治疗心肌重构的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003226913A1 (en) * 2002-04-04 2003-10-20 Novo Nordisk A/S Glp-1 agonist and cardiovascular complications
TWI362392B (en) * 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
ES2935300T3 (es) * 2010-05-05 2023-03-03 Boehringer Ingelheim Int Combiterapia
RS56998B1 (sr) * 2010-12-16 2018-05-31 Novo Nordisk As Čvrste kompozicije koje sadrže agonist glp-1 i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
US20130035281A1 (en) * 2011-02-09 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US9758560B2 (en) * 2011-09-06 2017-09-12 Novo Nordisk A/S GLP-1 derivatives
CN105722526B (zh) 2013-11-15 2020-12-08 诺和诺德股份有限公司 选择性pyy化合物及其用途
ES2928007T3 (es) * 2016-04-28 2022-11-14 Novo Nordisk As Semaglutida en afecciones cardiovasculares

Also Published As

Publication number Publication date
RU2018140900A (ru) 2020-05-28
HUE060040T2 (hu) 2023-01-28
ES2928007T3 (es) 2022-11-14
JP2019514925A (ja) 2019-06-06
PH12018502274B1 (en) 2024-02-28
US20190134162A1 (en) 2019-05-09
KR20220147712A (ko) 2022-11-03
MY202967A (en) 2024-05-31
DK3448416T3 (da) 2022-10-03
SI3448416T1 (sl) 2022-10-28
KR102778218B1 (ko) 2025-03-10
JP7221694B2 (ja) 2023-02-14
RS63630B1 (sr) 2022-10-31
US20250288649A1 (en) 2025-09-18
PH12018502274A1 (en) 2019-09-09
IL262390A (en) 2018-12-31
EP3448416B1 (en) 2022-08-10
AU2017256774A1 (en) 2018-11-01
AU2017256774B2 (en) 2024-07-11
KR20250038818A (ko) 2025-03-19
ZA202507395B (en) 2025-09-25
BR112018072020A2 (pt) 2019-02-12
CN109069589B (zh) 2022-09-06
MX2018012700A (es) 2019-01-30
ZA202507394B (en) 2025-09-25
MA44762A (fr) 2019-03-06
CN109069589A (zh) 2018-12-21
US20250262281A1 (en) 2025-08-21
WO2017186896A1 (en) 2017-11-02
KR20180135012A (ko) 2018-12-19
RU2768283C2 (ru) 2022-03-23
HRP20221150T1 (hr) 2022-11-25
CL2018003045A1 (es) 2018-12-14
CA3022535A1 (en) 2017-11-02
IL262390B1 (en) 2023-05-01
EP3448416A1 (en) 2019-03-06
AU2024227113A1 (en) 2024-10-31
PL3448416T3 (pl) 2022-11-07

Similar Documents

Publication Publication Date Title
BR112018004986A2 (ru)
BR112019008315A2 (ru)
BR112019009373A2 (ru)
BR202016030146U2 (ru)
CN303642013S (ru)
CN303538695S (ru)
CN303394128S8 (ru)
CN303535881S (ru)
CN303536045S (ru)
CN303536130S (ru)
CN303536131S (ru)
CN303536211S (ru)
CN303536218S (ru)
CN303536221S (ru)
CN303536231S (ru)
CN303536357S (ru)
CN303536360S (ru)
CN303536519S (ru)
CN303537247S (ru)
CN303537332S (ru)
CN303537406S (ru)
CN303537427S (ru)
CN303537447S (ru)
CN303537451S (ru)
CN303537475S (ru)